securities fraud

Class action filed against China Liberal Education Holdings for alleged pump-and-dump scheme involving fraudulent social media advisors, with stock collapsing January 30, 2025.

Class action lawsuit filed against $UGXY alleging securities fraud over misleading setrusumab trial data and OI patient safety disclosures.

Class action filed against Franklin BSP Realty Trust alleging executives made false statements about dividend sustainability from November 2024 to February 2026.

Rosen Law Firm sues Navan over false IPO disclosures regarding sales, marketing expenses. Lead plaintiff deadline April 24, 2026.

Rosen Law Firm files class action against Lakeland Industries ($LAKE) for allegedly concealing operational problems and misrepresenting financial performance between December 2023 and December 2025.

Rosen Law Firm files class action against $BSX over alleged false statements regarding U.S. Electrophysiology segment sustainability, resulting in earnings miss and weak guidance.

Ultragenyx Pharmaceutical faces securities fraud lawsuit after setrusumab trials failed. Stock crashed 42% in December; investors have until April 6, 2026, to join action.

Class action lawsuit alleges Oracle misrepresented AI capabilities and capital expenditures between June-December 2025, claiming material investor deception.

Robbins Geller files class action against Varonis Systems ($VRNS) alleging investor fraud over Q3 2025 missed guidance. Stock plummeted 49%; lead plaintiff deadline set for March 9, 2026.

PayPal faces securities fraud lawsuit over revenue misstatements; stock crashed 20% in February 2026 after surprise CEO change and missed earnings. Investor deadline: April 20, 2026.

BFA Law filed securities class action against Ardent Health ($ARDT) over accounting misrepresentations. Stock plunged 33% after November disclosure of revenue decline and liability reserve increase.

Law firm investigates $DRVN over potential securities fraud following 30% stock collapse tied to material accounting errors spanning 2023-2025.

Eos Energy ($EOSE) faces federal securities investigation after 39% stock plunge following $970M loss and missed revenue targets reaffirmed in November 2025.

$PLUG faces securities fraud suit alleging misrepresentation of $1.66B DOE loan access. Stock fell 17% after loan program suspension; investors have until April 3, 2026 to join.

NuScale faces securities class action over alleged ENTRA1 misrepresentation. Stock fell 12.4% after $495M payment disclosure. April 20 deadline to join.

CoreWeave faces securities lawsuit over data center delays; stock plunged 16% in November. Investors have until March 13, 2026, to join class action.

Eos Energy Enterprises missed 2025 revenue guidance significantly, reporting $114.2M versus $150-160M forecast, triggering 39% stock decline and class action lawsuit alleging false statements.

Class action lawsuit filed against $EOSE for allegedly concealing production ramp failures, battery line downtime, and quality delays from November 2025 to February 2026.

Class action lawsuit filed against $EOSE over alleged failure to disclose production issues. Stock fell 39.4% after missing revenue guidance by $36-46 million.

$MFIN shareholder ZimCal criticizes leadership over $31.25M debt maturity draining reserves, citing governance failures and poor strategic decisions.